- Home
- ANEB vs JHS Comparison
ANEB vs JHS Comparison
Compare ANEB & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- JHS
- Stock Information
- Founded
- ANEB 2020
- JHS 1973
- Country
- ANEB United States
- JHS United States
- Employees
- ANEB N/A
- JHS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- JHS Finance Companies
- Sector
- ANEB Health Care
- JHS Finance
- Exchange
- ANEB Nasdaq
- JHS Nasdaq
- Market Cap
- ANEB 111.8M
- JHS 131.4M
- IPO Year
- ANEB 2021
- JHS N/A
- Fundamental
- Price
- ANEB $2.75
- JHS $11.62
- Analyst Decision
- ANEB Buy
- JHS
- Analyst Count
- ANEB 2
- JHS 0
- Target Price
- ANEB $8.00
- JHS N/A
- AVG Volume (30 Days)
- ANEB 25.4K
- JHS 32.8K
- Earning Date
- ANEB 11-12-2025
- JHS 01-01-0001
- Dividend Yield
- ANEB N/A
- JHS 3.96%
- EPS Growth
- ANEB N/A
- JHS N/A
- EPS
- ANEB N/A
- JHS 0.02
- Revenue
- ANEB N/A
- JHS N/A
- Revenue This Year
- ANEB N/A
- JHS N/A
- Revenue Next Year
- ANEB N/A
- JHS N/A
- P/E Ratio
- ANEB N/A
- JHS $553.50
- Revenue Growth
- ANEB N/A
- JHS N/A
- 52 Week Low
- ANEB $0.80
- JHS $9.76
- 52 Week High
- ANEB $3.42
- JHS $11.25
- Technical
- Relative Strength Index (RSI)
- ANEB 62.06
- JHS 41.92
- Support Level
- ANEB $2.50
- JHS $11.54
- Resistance Level
- ANEB $2.76
- JHS $11.93
- Average True Range (ATR)
- ANEB 0.13
- JHS 0.16
- MACD
- ANEB 0.04
- JHS -0.03
- Stochastic Oscillator
- ANEB 79.03
- JHS 12.71
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About JHS John Hancock Income Securities Trust
John Hancock Income Securities Trust is a United States-based closed-ended diversified management investment company. Its primary objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.